Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Celcuity Inc (NQ: CELC ) 14.40 +0.16 (+1.12%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Celcuity Inc < Previous 1 2 3 4 Next > 12 Health Care Stocks Moving In Thursday's Intraday Session January 05, 2023 Via Benzinga Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session December 19, 2022 Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial. Via Benzinga Celcuity Appoints Polly Murphy, D.V.M., Ph.D., to Board of Directors September 14, 2022 Via ACCESSWIRE Celcuity: Q2 Earnings Insights August 11, 2022 Celcuity (NASDAQ:CELC) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Via Benzinga Celcuity Closes $100 Million Private Placement December 12, 2022 Via ACCESSWIRE Celcuity Presents Updated Results of Phase 1b Study of Gedatolisib in Patients with Advanced Breast Cancer at the 2022 San Antonio Breast Cancer Symposium December 09, 2022 Via ACCESSWIRE 12 Health Care Stocks Moving In Thursday's Intraday Session December 08, 2022 Via Benzinga Celcuity Announces First Patient Dosed in Phase 3 VIKTORIA-1 Clinical Trial of Gedatolisib for the Treatment of HR+/HER2- Advanced Breast Cancer December 07, 2022 Via ACCESSWIRE Celcuity to Present Additional Data for Gedatolisib at the 2022 San Antonio Breast Cancer Symposium November 22, 2022 Via ACCESSWIRE Earnings Scheduled For May 16, 2022 May 16, 2022 Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand. Via Benzinga Stocks That Hit 52-Week Lows On Friday April 08, 2022 During Friday's morning session, 234 stocks hit new 52-week lows. Interesting Facts About Today's 52-Week Lows: The largest company in terms of market cap... Via Benzinga Celcuity to Participate in the 13th Annual Craig-Hallum Alpha Select Conference November 10, 2022 Via ACCESSWIRE Celcuity Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update November 10, 2022 Via ACCESSWIRE Celcuity Inc. Schedules Release of Third Quarter 2022 Financial Results and Webcast/Conference Call November 03, 2022 Via ACCESSWIRE Celcuity Inc. Reports Second Quarter 2022 Financial Results and Provides Corporate Update August 11, 2022 Via ACCESSWIRE Earnings Outlook For Celcuity August 10, 2022 Celcuity (NASDAQ:CELC) is set to give its latest quarterly earnings report on Thursday, 2022-08-11. Here's what investors need to know before the announcement. Analysts estimate that Celcuity will... Via Benzinga Celcuity Inc. Schedules Release of Second Quarter 2022 Financial Results and Webcast/Conference Call August 04, 2022 Via ACCESSWIRE Celcuity to Participate in the Canaccord Genuity 42nd Annual Growth Conference August 03, 2022 Via ACCESSWIRE The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings July 19, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session July 18, 2022 Gainers Biophytis (NASDAQ:BPTS) stock moved upwards by 15.8% to $0.95 during Monday's after-market session. The company's market cap stands at $15.5 million. Via Benzinga Celcuity Announces FDA Breakthrough Therapy Designation for Gedatolisib for Treatment of HR+/HER2- Metastatic Breast Cancer July 18, 2022 MINNEAPOLIS, MN / ACCESSWIRE / July 18, 2022 / Celcuity Inc. (Nasdaq:CELC), a clinical-stage biotechnology company focused on development of targeted therapies for hormonally driven cancers, today... From Celcuity Inc. Via AccessWire Exposures Product Safety Celcuity to Participate in Upcoming Craig-Hallum and Jefferies Investor Conferences May 26, 2022 MINNEAPOLIS, MN / ACCESSWIRE / May 26, 2022 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing an integrated therapeutic and companion diagnostic strategy for treating... From Celcuity Inc. Via AccessWire Recap: Celcuity Q1 Earnings May 16, 2022 Celcuity (NASDAQ:CELC) reported its Q1 earnings results on Monday, May 16, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Celcuity beat estimated earnings by... Via Benzinga Celcuity Inc. Reports First Quarter 2022 Financial Results and Business Updates May 16, 2022 - Entered into $100 Million Private Placement Agreement - Finalized pivotal Phase 3 trial design for gedatolisib - Received FDA Fast Track designation for gedatolisib in HR+/HER2- advanced breast... From Celcuity Inc. Via AccessWire Exposures Product Safety The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More May 16, 2022 Biopharma stocks remained largely unchanged in the week ending May 13, with the defensive nature of the sector coming to its aid. Stocks reacted to the broader market move and earnings news from... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday May 17, 2022 On Tuesday, 123 stocks made new 52-week lows. Via Benzinga Celcuity Inc. Announces $100 Million Private Placement May 16, 2022 Proceeds to Advance Clinical Development of Gedatolisib Including Forthcoming Phase 3 Clinical Study (VIKTORIA-1) MINNEAPOLIS, MN / ACCESSWIRE / May 16, 2022 / Celcuity Inc. (Nasdaq:CELC), a... From Celcuity Inc. Via AccessWire Earnings Preview For Celcuity May 13, 2022 Celcuity (NASDAQ:CELC) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Celcuity will report... Via Benzinga Celcuity Inc. Schedules Release of First Quarter 2022 Financial Results and Webcast/Conference Call May 09, 2022 MINNEAPOLIS, MN / ACCESSWIRE / May 9, 2022 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing an integrated therapeutic and companion diagnostic strategy for treating... From Celcuity Inc. Via AccessWire Stocks That Hit 52-Week Lows On Wednesday April 20, 2022 On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new... Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.